RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Provides Updated Australian Paediatric Study Results, page-85

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,151 Posts.
    lightbulb Created with Sketch. 1293
    Afternoon Guys. I contacted Tony Keating about RAp's interpretations of the Pneumonia Result.

    I will not copy and paste his email as he has not given me explicit permission to post it here, but his response was that the results give the Team confidence in achieving success in the US Study. The NPA for Pneumonia may appear low, but when one considers the difficulty in clinical diagnosis, often providing a diagnosis for more than one illness (for example pneumonia and asthma for example) WHICH IS ACCURATE, BUT IS NOT SHOWN IN THE RESULTS. The most recent test results cannot be compared to the previous results as THEY ARE NOT THE SAME TEST.

    Once again, I commend TK and the Team at RAP. They are always transparent, always prepared, and always communicating with their shareholders.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.